[Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
D000328:Adult; D000368:Aged; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012830:Silicotuberculosis / Q000188:drug therapy; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D004338:Drug Combinations; D004977:Ethambutol; D012293:Rifampin
Vorläufige Ergebnisse einer 2-Phasen-Behandlung mit Rifampicin, Ethambutol und einem 3. Mittel bei chronisch-polyresistenten Tuberkulosen.